Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03789162 · ClinicalTrials.gov registry record
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
A clinical trial of Colorectal Cancer, sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 850
- Enrollment target
- 20
- Study locations
NCT03789162: Completed study of Colorectal Cancer, sponsored by Exact Sciences Corporation.
NCT03789162 is a study of Colorectal Cancer that has completed, run by Exact Sciences Corporation. The registered enrollment target is 850 participants, below the 1,509-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (44% lower). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03789162, a study of Colorectal Cancer, has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 850 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to collect de-identified, clinically-characterized stool and whole blood specimens for use in developing and evaluating the performance of new biomarker assays for the detection of colorectal cancer (CRC).
Conditions Studied
Study Locations (20)
California
- Alliance Research Institute - Canoga Park
- GW Research Inc - Chula Vista
- Tilda Research - Laguna Hills
- Clinical Trials Network - San Diego
Illinois
- Rush University Medical Center - Chicago
- DM Clinical Research/Southwest Gastroenterology - Oak Lawn
- Southern Illinois University School of Medicine - Springfield
- Carle Foundation Hospital dba Carle Cancer Center - Urbana
Louisiana
- MZS Research, LLC - Metairie
- Delta Research Partners - Monroe
- Louisiana Research Center, LLC - Shreveport
- Clinical Trials of America, LLC - West Monroe
Connecticut
- Gastroenterology Associates of Fairfield County, P.C. - Fairfield
- Connecticut Clinical Research Institute - Hartford
- Yale University - New Haven
Indiana
- Deaconess Clinic, Inc. - Evansville
- Digestive Research Alliance of Michiana, LLC - South Bend
Arizona
- Mayo Clinic - Arizona - Phoenix
Florida
- Guardian Angel Research Center - Tampa
Maryland
- Capitol Research - Rockville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 850 participants |
| Start Date | 2018-12-20 |
| Est. Completion | 2025-05-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03789162
The ClinicalTrials.gov registry entry for NCT03789162 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 850 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,509-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (44% lower). The listed sponsor is Exact Sciences Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03789162 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Illinois, Louisiana.
Frequently Asked Questions
What is clinical trial NCT03789162 about?
NCT03789162 is a clinical study titled "Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast". The primary objective of this study is to collect de-identified, clinically-characterized stool and whole blood specimens for use in developing and evaluating the performance of new biomarker assays for the detection of colorectal cancer (CRC).
What is the current status of trial NCT03789162?
This trial is currently completed. The enrollment target is 850 participants. The study started on 2018-12-20. Estimated completion is 2025-05-29.
What conditions does trial NCT03789162 study?
This clinical trial studies the following conditions: Colorectal Cancer.
Who is sponsoring clinical trial NCT03789162?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03789162 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.